Alatrofloxacin
Alatrofloxacin (also known under the brand name Trovan IV) is a type of fluoroquinolone antibiotic. This compound, developed by the pharmaceutical company Pfizer, is administered as a mesylate salt[1].
Development and Composition[edit]
Alatrofloxacin belongs to the fluoroquinolone class of antibiotics, which are used to treat a range of bacterial infections due to their ability to interfere with the enzymes that bacteria require for DNA repair and replication.
The specific compound of alatrofloxacin is delivered in the form of a mesylate salt. This formulation ensures enhanced solubility and stability of the drug, making it suitable for intravenous administration.
Association with Trovafloxacin[edit]
Trovafloxacin is another compound related to alatrofloxacin. While both are associated with the brand name Trovan, they have distinct chemical structures and pharmacological properties.
Market Withdrawal[edit]
Both alatrofloxacin and trovafloxacin were withdrawn from the U.S. market in 2001. The decision to remove these drugs from the market followed concerns regarding potential side effects and adverse reactions.
See Also[edit]
References[edit]
- ↑ [1]
